These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5353483)

  • 41. Acetazolamide therapy with renal complications.
    Charron RC; Feldman F
    Can J Ophthalmol; 1974 Jul; 9(3):282-4. PubMed ID: 4844579
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (acetazolamide) on citric acid excretion in the urine].
    OTTO H
    Klin Wochenschr; 1958 Jul; 36(13):633-6. PubMed ID: 13564739
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acetazolamide and renal calculi].
    Røise O; Otnes B
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):25-6. PubMed ID: 3952691
    [No Abstract]   [Full Text] [Related]  

  • 44. [The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi].
    Bichler KH; Henzler B; Strohmaier WL; Stahl C; Korn S
    Urologe A; 1995 Nov; 34(6):437-43. PubMed ID: 8848853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Basic studies on the cause of urolithiasis. I. Stone producing substances and experimental stone formation with administration of drugs].
    Matsuo M
    Hinyokika Kiyo; 1966 Sep; 12(9):847-59. PubMed ID: 6009215
    [No Abstract]   [Full Text] [Related]  

  • 47. [Indications for acetazolamide].
    Vetter W
    Internist (Berl); 1997 Sep; 38(9):867. PubMed ID: 9410838
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination of systemic acetazolamide and topical dorzolamide.
    Epstein R; Brown SV; Dennis RF; Konowal-Allen A
    Ophthalmology; 1998 Sep; 105(9):1581-2. PubMed ID: 9754157
    [No Abstract]   [Full Text] [Related]  

  • 49. Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis.
    Elinav E; Ackerman Z; Gottehrer NP; Heyman SN
    Ann Emerg Med; 2002 Aug; 40(2):259-60. PubMed ID: 12140510
    [No Abstract]   [Full Text] [Related]  

  • 50. Acetazolamide-induced thrombocytopenia.
    Kodjikian L; Durand B; Burillon C; Rouberol F; Grange JD; Renaudier P
    Arch Ophthalmol; 2004 Oct; 122(10):1543-4. PubMed ID: 15477470
    [No Abstract]   [Full Text] [Related]  

  • 51. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of urine citrate excretion and the production of renal calcinosis in the rat by acetazoleamide (diamox) administration.
    HARRISON HE; HARRISON HC
    J Clin Invest; 1955 Nov; 34(11):1662-70. PubMed ID: 13271550
    [No Abstract]   [Full Text] [Related]  

  • 54. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Grover S; Janowicz MJ
    Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephrolithiasis with dorzolamide.
    Carlsen J; Durcan J; Zabriskie N; Swartz M; Crandall A
    Arch Ophthalmol; 1999 Aug; 117(8):1087-8. PubMed ID: 10448757
    [No Abstract]   [Full Text] [Related]  

  • 56. Acetazolamide-associated nephrocalcinosis in a transplant kidney.
    Parikh JR; Nolan RL; Bannerjee A; Gault MH
    Transplantation; 1995 Jun; 59(12):1742-3. PubMed ID: 7604446
    [No Abstract]   [Full Text] [Related]  

  • 57. Acetazolamide and renal stone formation.
    Parfitt AM
    Lancet; 1970 Jul; 2(7664):153. PubMed ID: 4194537
    [No Abstract]   [Full Text] [Related]  

  • 58. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sodium-calcium ratio in the urine of patients with nephrolithiasis].
    Lorenz J; Dabrowska B; Janukowicz-Lorenz H
    Pol Tyg Lek; 1972 Sep; 27(38):1474-6. PubMed ID: 5076481
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal stone.
    Modlin M
    Br J Clin Pract; 1968 Dec; 22(12):531-5. PubMed ID: 4302529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.